ANAVEX2-73

blarcamesine · Anavex Life Sciences Corp.

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for ANAVEX2-73, covering 2018-11-28 to 2024-08-12. Get the full timeline:

Most recent: Clinical Trial Update: OLE of Phase 2b/3 Study ANAVEX2-73-AD-004 [Phase 2, Phase 3]